Addex Therapeutics Ltd ADXN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.12% | 5.03% | -16.62% | -- | -19.33% |
| Total Depreciation and Amortization | 155.20% | 362.96% | 3.85% | -- | -91.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.48% | 20.38% | 18.10% | -- | 20.67% |
| Change in Net Operating Assets | 154.16% | -306.52% | 8.70% | -- | -103.89% |
| Cash from Operations | 39.33% | -26.02% | -16.32% | -- | -2,385.07% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -105.73% | -- | -- |
| Cash from Investing | -- | -- | -105.73% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,943.75% | 15.79% | -5.56% | -- | 0.00% |
| Issuance of Common Stock | 360.00% | -13.53% | -76.79% | -- | -- |
| Repurchase of Common Stock | -390.63% | 50.77% | -140.74% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -240.00% | -66.67% | -- | 1,882.14% |
| Cash from Financing | 339.16% | -11.83% | -79.02% | -- | 5,550.00% |
| Foreign Exchange rate Adjustments | 448.72% | -105.26% | 9.52% | -- | -145.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.33% | -30.70% | -382.91% | -- | -6,656.47% |